New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

This walking tour explores Shenzhen’s corporate landscape, developed for global firms and regional headquarters.

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...

Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...

But more big tests loom with trade talks still continuing between the Trump administration and counterparts in China and the ...

Global consumption patterns are shifting and are driven by long-term changes in supply chains, pricing and consumer behaviour ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Welcome to our live blog tracking the latest news and developments from Canada. Stay updated with real-time insights into the ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...